Web Analysis for Esograzia - esograzia.net
2.31
Rating by CuteStat
esograzia.net is 1 decade 3 years old. It is a domain having net extension. It has a global traffic rank of #344306 in the world. This website is estimated worth of $ 14,580.00 and have a daily income of around $ 27.00. As no active threats were reported recently by users, esograzia.net is SAFE to browse.
PageSpeed Score
44
Siteadvisor Rating
Not Applicable
Traffic Report
| Daily Unique Visitors: | 2,445 |
| Daily Pageviews: | 9,780 |
Estimated Valuation
| Income Per Day: | $ 27.00 |
| Estimated Worth: | $ 14,580.00 |
Search Engine Indexes
| Google Indexed Pages: | 144 |
| Bing Indexed Pages: | 1 |
Search Engine Backlinks
| Google Backlinks: | 1 |
| Bing Backlinks: | Not Applicable |
Safety Information
| Google Safe Browsing: | No Risk Issues |
| Siteadvisor Rating: | Not Applicable |
| WOT Trustworthiness: | Not Applicable |
| WOT Child Safety: | Not Applicable |
Website Ranks & Scores
| Alexa Rank: | 344,306 |
| Domain Authority: | 19 ON 100 |
Web Server Information
Hosted IP Address:
88.198.226.154
Hosted Country:
DE
Location Latitude:
49.4478Location Longitude:
11.0683Domain Information
| Domain Registrar: |
WEBNAMES.CA INC
|
|---|---|
| Registration Date: | Sep 23, 2010, 12:00 AM 1 decade 3 years 6 months ago |
| Last Modified: | May 28, 2012, 12:00 AM 1 decade 1 year 10 months ago |
| Expiration Date: | Sep 23, 2013, 12:00 AM 1 decade 6 months 3 weeks ago |
Domain Nameserver Information
| Host | IP Address | Country | |
|---|---|---|---|
| ns1.dodns.net |
|
192.174.68.11 |
Austria
|
| ns2.dodns.net |
|
176.97.158.11 |
Austria
|
| ns3.dodns.net |
|
176.97.158.11 |
Austria
|
Similarly Ranked Websites
ParkNow
Find, book, and pay for your parking with one seamless app. With just a few clicks, you can eliminate the hassle of parking.
344,309
$
25,920.00
Leading a Culture of Safety | American College of Healthcare Executive
344,309
$
25,920.00
Investor Relations | GW Pharmaceuticals
The Investor Relations website contains information about GW Pharmaceuticals's business for stockholders, potential investors, and financial analysts.
344,310
$
25,920.00
